knowledge -WSS

knowledge

author：entertainment 2025-10-02 22:40:19 - browse：4

LIONEL BONAVENTURE/AFP via Getty Images

On Tuesday, Duke Health and Microsoft announced a five-year partnership that will support artificial intelligence applications in medicine, with a focus on building out infrastructure such as cloud-based data platforms.

Duke Health and Microsoft are both members of the Coalition for Health AI, a group of companies, hospitals, and federal agencies that formed late last year to develop guidelines for the responsible use of AI in medicine. “We have all these operational things we want to do in the health system, and we also have an academic interest in trustworthy AI,” said Jeffrey Ferranti, senior vice president and chief digital officer of Duke Health.

So Duke and Microsoft will collaborate within the newly-established Duke Health AI Innovation Lab and Center of Excellence, where researchers can develop new AI tools “while paying attention to some of the things that could go wrong,” said Ferranti. “Because there are a lot of things that can go wrong as we introduce new technology.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Even great ERs can’t make up for American health disparities

WSS

Setback for rare diseases as Taysha Gene Therapies pulls back

New Ultima Genomics DNA sequencer can read genome for $100

General Catalyst, Summa Health deal will turn on physician buy

The United States is paying nearly triple for new Covid vaccines

6 solutions to address cancer drug shortages and others

Congressmen charge Covid hearing ‘could have been an email’

hotspot

knowledge

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

What will Novo Nordisk's VC do with its influx of cash?

Drug repurposing or repositioning? The language matters

Health insurers' Q3 question: how much care are people getting?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What will Novo Nordisk's VC do with its influx of cash?

The cancer drug shortage isn’t new — and neither are the solutions

Commercial surrogacy can be ethical, despite pope’s claims

At least 13 dead in Texas as scorching temps continue

Lawsuit highlights wrinkle for disputes over surprise medical bills

knowledge

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Vertex non

General Catalyst, Summa Health deal will turn on physician buy

General Catalyst, Summa Health deal will turn on physician buy

Nobel honors Karikó and Weissman's enduring partnership

Vertex non

leisure time

explore

focus

knowledge